C000594389

2 trials

Sponsors

Izutsu Koji, Yonemori Kan

Conditions

extranodal NK/T-cell lymphoma, nasal type (ENKL) ENKLunresectable alveolar soft tissue sarcoma advanced alveolar soft part sarcoma

Phase 2

Atezolixumab in patients with relapsed/refractory NK/T-cell lymphoma

Active, not recruitingJPRN-jRCT2031190177

Izutsu Kojiextranodal NK/T-cell lymphoma, nasal type (ENKL) ENKL

Start: 2020-07-06Target: 20Updated: 2026-06-29

NCCH1907/MK008 trial

Active, not recruitingJPRN-jRCT2031200041

Yonemori Kanunresectable alveolar soft tissue sarcoma advanced alveolar soft part sarcoma

Start: 2020-05-28Target: 20Updated: 2026-06-29

Related Papers

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial

Blood Advances2026-05-20